Contract Pharmaceutical Fermentation Services Market In-depth Forecast Study Highlights Growth in CAGR% and Revenue (US$Mn) till 2026

Posted on 2019-09-13 by Mark Hub in Healthcare // 0 Comments

Highly Fragmented Market Necessitating Adoption of Unique Strategies

The contract pharmaceutical services manufacturing market is fairly fragmented, with manifold contract manufacturing organizations (CMOs) showing high dependence on limited number of clients. To gain a competitive edge in this highly fragmented market, contract pharmaceutical fermentation services’ providers are creating unique strategies based on prevailing pharmaceutical industry landscape and trends.

Get Report Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1517

To capitalize on the growing trend of pharmaceutical companies avoiding internal capacity investment to embrace outsourcing, contract pharmaceutical fermentation services’ providers continue to embed advancing technology in their processes. Further, several contract pharmaceutical fermentation services providers are indulging into collaborations with local integrators. To move ahead of the competition in contract pharmaceutical fermentation services market, leading players are focusing on extending and diversifying their businesses, as pharmaceutical industries turn to outsourcing to CMOs to underpin gains.

January 2019 – A leading player in contract pharmaceutical fermentation services market, AbbVie, has collaborated with a privately held immunotherapy firm, Tizona Therapeutics, to manufacture and commercialize CD39-targeted therapeutics, such as TTX-030, an antibody for treating cancer.
March 2018 – AbbVie, Inc. won Life Science Leader CMO award for contract manufacturing and reinforced its position in contract pharmaceutical fermentation services market.
January 2019 – Another leading player in contract pharmaceutical fermentation services market, Boehringer Ingelheim International GmbH announced commencement of its capacity expansion at the company’s commercial manufacturing site for biologics located in China.
December 2018 – Lonza announced plans about establishing a bio manufacturing base in China. Lonza has inked an agreement with GE Healthcare under which GE Healthcare will provide a biologics facility to a site in Guangzhou. The base is anticipated to be functional in 2020.

Detailed profiles of other leading market players operating in contract pharmaceutical fermentation services market have also been included in contract pharmaceutical fermentation services market report. Key players operating in contract pharmaceutical fermentation services market include AbbVie, Inc., Aumgene Biosciences, EKF Diagnostics-Stanbio, Boehringer Ingelheim International GmbH, Biocon, AMRI, Pfizer, Lonza, CordenPharma International, and Fujifilm Holdings Corporation.

Evolving Use of Fermentation Techniques for Developing Active Pharmaceutical Ingredients Creating Opportunities

The overall pharmaceutical industry has been changing and developing at a rapid pace with several manufacturing firms struggling with massive challenges caused by high market growth, frequently changing regulations, novel therapy and medicine forms as well as progressing digitization. To address such challenges, pharmaceutical medicines’ manufacturers are increasingly mimicking already existing manufacturing equipment to further transfer them to contract manufacturing service providers. Being the core for production of a wide range of pharmaceutical based products, microbial fermentation has frequently evolved in recent past. As a result several pharmaceutical manufacturers are deriving medical products from fermented products encompassing active pharmaceutical ingredients (API), which is further creating demand for contract pharmaceutical fermentation services for bulk supply. The growing adoption of microbial fermentation as a production method for therapeutic proteins, fragmented antibodies, intermediates, peptides, etc., has become an optimal economic route for pharmaceutical companies to meet production demand and market delivery time. This burgeoning demand for fermentation processes in tandem with the rapidly expanding pharmaceutical industry are likely to fuel growth in contract pharmaceutical fermentation services market in forthcoming years.

Outlook Complete Research report with TOC @ https://www.factmr.com/report/1517/contract-pharmaceutical-fermentation-services-market

Growing Demand for Time-Efficient Drug Development to Underpin Market Growth

Though the pharmaceutical industry is rapidly changing and accelerating, the basic understanding of diverse diseases at a molecular level is improving constantly. This growing understanding of different diseases is further accelerating the demand for faster production. Amid the burgeoning production demand, several pharmaceutical companies are increasingly collaborating with contract pharmaceutical fermentation services’ providers to introduce innovative molecules in the market. Further the growing prevalence of diverse diseases, such as cancer, anemia, diabetes, rheumatoid arthritis, etc., is likely to boost demand for diverse pharmaceutical products with applications in disease management. This widespread prevalence of diseased population that is constantly requiring therapies and treatment is triggering the demand for time-efficient drug production. As contract pharmaceutical fermentation services’ providers offer reduced time-to-market for various key pharmaceutical products by collaborating with molecule owners and giving platforms for time-efficient drug development and other analytical services, their demand is set to grow. This growing trend is likely to trigger growth in contract pharmaceutical fermentation services market during the forecast period.

Complexities Associated with Contract Pharmaceutical Fermentation Services Dampening Market Growth

Despite extensive utilization of fermentation processes, the technology is yet to gain maturity like chemical synthesis, in terms of adoption of mathematical models and optimization techniques. The significant fermentation challenges, such as scale up and scale down fermentation, controlling insightful process parameters, mass transfer, and establishing novel sensors have been restraining market growth. Further the challenges associated with advanced therapy medicinal products that demand thoughtful and appropriate facility design and equipment continue to hinder contract pharmaceutical fermentation services market growth. As contract pharmaceutical fermentation services need huge capital investment for set-ups and fulfilling technical staff requirements, several market players deal with large-scale fermentation challenges. Such challenges are likely to hamper growth in contract pharmaceutical fermentation services market in forthcoming years.

Growing Need for Differentiation and Biosimilar and Biologic Manufacturing Presenting Strong Growth Opportunities

With manifold manufacturers, contract pharmaceutical fermentation services market remains highly fragmented, propelling service providers to seek novel and innovative ways of differentiating their services from counterparts. Amid the rigorous competition in contract pharmaceutical fermentation services market, the service providers are increasingly focusing on value-added services which is likely to bring tremendous changes in the market, thereby paving way for growth opportunities.

About the Report

The report on contract pharmaceutical fermentation services market offers a comprehensive evaluation of the business opportunities in contract pharmaceutical fermentation services market. It also offers insights on contract pharmaceutical fermentation services market outlook, and list of service providers in the contract pharmaceutical fermentation services market for the duration from 2018 to 2026.

Inquire Now or Share Questions if any @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1517

Segmentation

The Fact.MR report on contract pharmaceutical fermentation services offers a comprehensive taxonomy of the contract pharmaceutical fermentation services market on the basis of contract pharmaceutical fermentation service type, platform, product type, and end user of contract pharmaceutical fermentation services. On the basis of service type, the global contract pharmaceutical fermentation services market has been segmented into development services and commercial services. On the basis of platform, the global contract pharmaceutical fermentation services market has been segmented into bacterial and fungal/yeast. Based on product type, the global contract pharmaceutical fermentation services market has been segmented into bio-therapeutics, enzymes, peptides, plasmids, cytokines & growth factors, vaccines, others (fusion proteins, etc.). By end user, the global contract pharmaceutical fermentation services market has been segmented into pharmaceutical companies, biotechnology companies, animal health companies, and academic & research institutes. Based on region, the contract pharmaceutical fermentation services market has been bifurcated into North America, Latin America, Europe, and Asia Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick